Partners Group Lending Fund reports April 30 NAV of $1.5013/unit; portfolio $501.1M

Partners Group Lending Fund, LLC

NAV per Unit as of April 30, 2026: Class I and Class M both $1.5013; aggregate NAV $317.2M with $209.0M debt.
Portfolio fair value $501.1M across 59 companies; 93.2% first lien/unitranche loans, 5.1% CLO debt, 1.7% opportunistic credit.
Top industries: Software 26.0%, Health Care Providers 11.0%, Professional Services 10.5%.
Largest holding: PT Intermediate Holdings III, LLC at 3.5% of portfolio ($21.0M par value).
Sold 13,322 Class I units ($20k) and 26,549 Class M units ($39.9k) in May 2026 via Reg D exemption.

Machine-readable event card

schema_version: secwatch.filing_event.v1
accession: 0001398344-26-010206
form_type: 8-K
ticker: null
cik: 0001938649
company_name: Partners Group Lending Fund, LLC
filed_at: 2026-06-02T21:12:15+00:00
discovered_at: 2026-06-02T21:13:28.863418+00:00
generated_at: 2026-06-02T21:13:45.510578+00:00
sec_items: ["3.02", "8.01"]
event_type: other_material
sentiment: neutral
materiality_score: 0.4
calibrated_materiality_score: 0.4
confidence: high
secwatch_canonical_url: https://secwatch.observer/filing/0001398344-26-010206
json_url: https://secwatch.observer/filing/0001398344-26-010206.json
markdown_url: https://secwatch.observer/filing/0001398344-26-010206.md
text_url: https://secwatch.observer/filing/0001398344-26-010206.txt
edgar_index_url: https://www.sec.gov/Archives/edgar/data/1938649/000139834426010206/0001398344-26-010206-index.htm
edgar_primary_document_url: https://www.sec.gov/Archives/edgar/data/1938649/000139834426010206/fp0099279-1_8kixbrl.htm
generated_by_model: deepseek-v4-flash:cloud@v2
review_status: machine_generated
human_reviewed: false
corrected: false
correction_note: null
correction_timestamp: null
superseded_by: null

Jaguar Health issues 64,668 common shares for Series Q Preferred; annual meeting adjourned to June 8

Jaguar Health, Inc. June 2, 2026, 4:10 PM ET other_material Items 1.01, 3.02, 8.01, 9.01

same SEC item: 3.02, 8.01 same event type: other_material similar materiality

Starlink AI Acquisition closes partial over-allotment, adds $5M to trust

Starlink AI Acquisition Corp June 2, 2026, 4:05 PM ET other_material Items 3.02, 8.01, 9.01

same SEC item: 3.02, 8.01 same event type: other_material similar materiality

NRx Pharmaceuticals proposes public offering of common stock; terms not set

NRX Pharmaceuticals, Inc. June 2, 2026, 5:30 PM ET other_material Items 8.01, 9.01